LEA
TMO icon

Legacy Edge Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Legacy Edge Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$741K Sell
1,477
-13
-0.9% -$6.24K 0.07% 113
2026
Q1 		$732K Sell
1,490
-91
-6% -$49.4K 0.08% 106
2025
Q4 		$916K Sell
1,581
-62
-4% -$35.1K 0.1% 101
2025
Q3 		$797K Sell
1,643
-73
-4% -$34K 0.09% 100
2025
Q2 		$696K Buy
1,716
+66
+4% +$27.6K 0.09% 98
2025
Q1 		$821K Sell
1,650
-4
-0.2% -$2.17K 0.13% 84
2024
Q4 		$858K Buy
1,654
+54
+3% +$29.7K 0.14% 82
2024
Q3 		$990K Sell
1,600
-19
-1% -$11.2K 0.16% 75
2024
Q2 		$895K Buy
1,619
+39
+2% +$22.3K 0.17% 74
2024
Q1 		$918K Sell
1,580
-64
-4% -$35.9K 0.19% 67
2023
Q4 		$873K Buy
+1,644
New +$796K 0.2% 70

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legacy Edge Advisors's TMO Position: Q2 2026 in Review

Legacy Edge Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.87% in Q2 2026, selling an estimated $6.24K and leaving 1,477 shares worth $741K. The position accounts for 0.07% of the portfolio, ranked #113.

Legacy Edge Advisors first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $990K in Q3 2024. 2,629 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Legacy Edge Advisors held 1,477 shares of Thermo Fisher Scientific worth $741K as of Q2 2026.
  • Legacy Edge Advisors sold 13 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.24K.
  • Thermo Fisher Scientific made up 0.07% of Legacy Edge Advisors's portfolio in Q2 2026, its #113 holding.
  • Legacy Edge Advisors first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Legacy Edge Advisors's Thermo Fisher Scientific position peaked at $990K in Q3 2024.
  • 2,629 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Legacy Edge Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.